Gadoxetic acid-enhanced mri surveillance
1 paper2 findings
- 1 lab in 1 country
- Funder: Bayer Korea
- Humans1
Outcomes
2Number of surveillance examinations
downin humans1−44%
1 study
Number of surveillance examinations
downin humans1−44%
Gadoxetic acid-enhanced mri surveillance decreases number of surveillance examinations in humans (-44.2%).
Human trialcirrhosis
European radiology15 Aug 2026
Surveillance failure
no changein humans1
1 study
Surveillance failure
no changein humans1
Gadoxetic acid-enhanced mri surveillance has no effect on surveillance failure in humans (0% (95% CI: 0-24.7%)).
Human trialcirrhosis
European radiology15 Aug 2026
Latest
1 in 12 monthsEuropean Radiology
Risk-stratified MRI surveillance for hepatocellular carcinoma in cirrhosis: a prospective cohort study
Cohort study of 86 peopleCirrhosis